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On page 23, Figure 1 Notes section was marked incorrectly. The correct Notes should read as follows:

**Figure 1** Propensity score over time for GLP-1 versus basal insulin initiators

**Notes:** Blue: insulin, red: GLP-1.

**Abbreviation:** GLP-1, glucagon-like peptide-1 analogs.

On page 24, Figure 2 Notes section was marked incorrectly. The correct Notes should read as follows:

**Figure 2** Propensity score over time for DPP-4i versus sulfonylurea initiators. **Notes:** Blue: sulfonylurea, red: DPP-4i.

**Abbreviation:** DPP-4i, dipeptidyl peptidase-4 inhibitors.

On Page 3 of Supplementary materials, Figure S2 caption was shown incorrectly. The correct caption should read as follows:

**Figure S2** Histograms of propensity score over time. Intention-to-treat and per-protocol cohorts of all identified initiators of GLP-1 and insulin, and DPP-4i and sulfonylurea, respectively. Blue: insulin and sulfonylurea initiators, respectively. Red: GLP-1 and DPP-4i initiators, respectively.

Despite the above corrections, the interpretation of these figures in the published proof and the Supplementary materials was correct.
